跳至主要内容
临床试验/ITMCTR2100005398
ITMCTR2100005398尚未招募1 期

Study on the mechanism of Lingnan fire needling on brain gut axis in functional dyspepsia with liver depression and spleen deficiency syndrome

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1) Age between 18-65 years old;
  • 2) Accord with the diagnostic criteria of functional dyspepsia;
  • 3) Accord with the syndrome of liver depression and spleen deficiency in traditional Chinese medicine;
  • 4) The frequency and severity of symptoms of functional dyspepsia were above grade II;
  • 5) Patients volunteered to participate in the study, signed informed consent and were willing to cooperate with the study.

排除标准

  • 1) Patients who had received functional dyspepsia drugs or acupuncture treatment within 2 weeks before screening;
  • 2) Patients who underwent any surgery within 2 weeks before screening;
  • 3) Patients with diabetes, coagulation disorders or severe skin diseases
  • 4) During screening examination, the alanine aminotransferase (ALT) or aspartate aminotransferase (AST) of the patient is greater than or equal to 1.5 times of the upper limit of normal value specified by the center, or the endogenous creatinine clearance (CCR) is greater than the upper limit of normal value specified by the center;
  • 5) During screening examination, the total white blood cell count (WBC) of patients is greater than 10.0x109/l or less than 1.0x109/l;
  • 6) The patient has a history of immune deficiency diseases (such as HIV), or a history of cancer, malignant tumor, or autoimmune diseases, or serious cardiovascular and cerebrovascular diseases, or other diseases that may significantly reduce life expectancy;
  • 7) Have any history of diseases that may affect program compliance (such as severe mental disorders, cognitive impairment, drug abuse or addiction);
  • 8) Pregnant or lactating women, or those who are unwilling / unable to take effective contraceptives;
  • 9) Those who are known to be allergic to the ingredients contained in the drug used in this study;
  • 10) Those who have participated in any drug clinical trial within 6 months before screening examination;
  • 11) The investigator judged that patients should not participate in this study

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

相似试验